Thromb Haemost 2016; 116(06): 1165-1771
DOI: 10.1160/TH16-02-0113
Stroke, Systemic or Venous Thromboembolism
Schattauer Publishers Schattauer

Whole exome sequencing analysis reveals TRPV3 as a risk factor for cardioembolic stroke/subtitle

Caty Carrera
1   Neurovascular Research Laboratory, Valld’Hebron Institute of Research, Universitat Autonoma de Barcelona, Barcelona, Spain
,
Jordi Jiménez-Conde
2   Department of Neurology, Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d’Investigacions Mediques), Universitat Autonoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Barcelona, Spain
,
Sophia Derdak
3   National Center for Genome Analysis, CNAG, Barcelona, Spain
,
Kelly Rabionet
4   Center for Genomic Regulation, IMIM, Barcelona, Spain
,
Cristofol Vives-Bauzá
5   Research Unit, Son Espases University Hospital, IdISPa, Palma de Mallorca, Spain
,
Carolina Soriano-Tárrega
2   Department of Neurology, Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d’Investigacions Mediques), Universitat Autonoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Barcelona, Spain
,
Eva Giralt-Steinhauer
2   Department of Neurology, Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d’Investigacions Mediques), Universitat Autonoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Barcelona, Spain
,
Marina Mola-Caminal
2   Department of Neurology, Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d’Investigacions Mediques), Universitat Autonoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Barcelona, Spain
,
Rosa M. Diaz-Navarro
6   Neurology Department, Son Espases University Hospital, IdISPa, Palma de Mallorca, Spain
,
Silvia Tur
6   Neurology Department, Son Espases University Hospital, IdISPa, Palma de Mallorca, Spain
,
Elena Muiño
7   Stroke Pharmacogenomics and Genetics, Fundacio Docencia i Recerca Mutua Terrassa, Mutua de Terrassa Hospital, Terrassa (Barcelona), Spain
,
Cristina Gallego-Fabrega
7   Stroke Pharmacogenomics and Genetics, Fundacio Docencia i Recerca Mutua Terrassa, Mutua de Terrassa Hospital, Terrassa (Barcelona), Spain
,
Sergi Beltran
3   National Center for Genome Analysis, CNAG, Barcelona, Spain
,
Jaume Roquer
2   Department of Neurology, Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d’Investigacions Mediques), Universitat Autonoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Barcelona, Spain
,
Agustin Ruiz
8   ACE Foundation, Institut Català de Neurociències Aplicades, Research Center, Barcelona, Spain
,
Oscar Sotolongo-Grau
8   ACE Foundation, Institut Català de Neurociències Aplicades, Research Center, Barcelona, Spain
,
Jurek Krupinski
9   Neurology Unit, Neuroscience Department, Mutua de Terrassa Hospital, Terrassa (Barcelona), Spain
,
Jin-Moo Lee
10   Washington University School of Medicine, St. Louis, Missouri, USA
,
Carlos Cruchaga
10   Washington University School of Medicine, St. Louis, Missouri, USA
,
Pilar Delgado
1   Neurovascular Research Laboratory, Valld’Hebron Institute of Research, Universitat Autonoma de Barcelona, Barcelona, Spain
,
Rainer Malik
11   Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians University, Munich, Germany
,
Brad B. Worrall
12   Departments of Neurology and Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA
,
Sudha Seshadri
13   Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
,
Joan Montaner
1   Neurovascular Research Laboratory, Valld’Hebron Institute of Research, Universitat Autonoma de Barcelona, Barcelona, Spain
,
Israel Fernández-Cadenas
7   Stroke Pharmacogenomics and Genetics, Fundacio Docencia i Recerca Mutua Terrassa, Mutua de Terrassa Hospital, Terrassa (Barcelona), Spain
,
the Metastroke Consortium, ISGC Consortium and Genestroke Consortium› Author Affiliations

Financial support: I. F-C. is supported by the Miguel Servet program(CP12/03298), Instituto de Salud Carlos III. The Neurovascular Research Laboratory is supported by the Spanish stroke research network (INVICTUS) and the European Stroke Network (EUSTROKE 7FP Health F2–08–202213). The IMIM-Hospital del Mar group is supported by RIC, RD12/0042/0020 FEDER.
Further Information

Publication History

Received 11 February 2016

Accepted after major revision: 15 August 2016

Publication Date:
09 March 2018 (online)

Preview

Summary

Genetic studies suggest that hundreds of genes associated with stroke remain unidentified. Exome sequencing proves useful for finding new genes associated with stroke. We aimed to find new genetic risk factors for cardioembolic stroke by analysing exome sequence data using new strategies. For discovery, we analysed 42 cardioembolic stroke cases and controls with extreme phenotypes (cohort 1), and for replication, 32 cardioembolic stroke cases and controls (cohort 2) using the SeqCapExome capture kit. We then analysed the replicated genes in two new cohorts that comprised 834 cardioembolic strokes and controls (cohort 3) and 64,373 cardioembolic strokes and controls (cohort 4). Transcriptomic in-silico functional analyses were also performed. We found 26 coding regions with a higher frequency of mutations in cardioembolic strokes after correcting for the number of mutations found in the whole exome of every patient. The TRPV3 gene was associated with cardioembolic stroke after replication of exome sequencing analysis (p-value-discovery: 0.018, p-value-replication: 0.014). The analysis of the TRPV3 gene using polymorphisms in cohort 3 and 4 revealed two polymorphisms associated with cardioembolic stroke in both cohorts, the most significant polymorphism being rs151091899 (p-value: 3.1 × 10−05; odds ratio: 5.4) in cohort 3. The genotype of one polymorphism of TRPV3 was associated with a differential expression of genes linked to cardiac malformations. In conclusion, new strategies using exome sequence data have revealed TRPV3 as a new gene associated with cardioembolic stroke. This strategy among others might be useful in finding new genes associated with complex genetic diseases.